[1-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-yl)-piperidin-3-yl]-methanol, 95.0%, 250mg

6-Chloro-5-fluoronicotinaldehyde, 95.0%, 1g

N,N-dimethylformamide, min. 99.5%, for synthesis, 10 l, plastic packaging.

1-Methyl-4-(4-methylpiperidin-4-yl)piperazine trihydrochloride, 95+%, 1g

tert-butyl (3R,4R)-3-amino-4-(hydroxymethyl)pyrrolidine-1-carboxylate, 97.0%, 100mg

2',6'-dimethyl-3-(3-methylphenyl)propiophenone, 97.0%, 1g

2-Chloro-6-ethoxyquinazoline, 97%, 100mg

5-(3-Chlorophenyl)thiazolidine-2,4-dione, 250mg

Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate, 95.0%, 1g

tert-Butyl 3a-(4-bromophenyl)hexahydropyrano[3,4-b]pyrrole-1(2H)-carboxylate, 97%, 100mg

6-Hydroxy-1-naphthoic acid, 95.0%, 25g

8-Bromo-6-methylimidazo[1,2-a]pyridine-3-carbaldehyde, 98%, 100mg

2-(3-Nitrophenyl)-4-(2-hydroxyphenyl)thiazole, 1g